PBM Price-Fixing Cases Advance in Federal Courts
Pharmacy benefit managers face consolidated litigation alleging anticompetitive drug pricing practices that inflated costs for consumers and plan sponsors over more than a decade. Proceedings are expected to run through late 2026.